04630nam 22008415 450 991063108250332120250628110036.03-031-11814-610.1007/978-3-031-11814-2(CKB)5710000000094996(DE-He213)978-3-031-11814-2(oapen)https://directory.doabooks.org/handle/20.500.12854/94992(MiAaPQ)EBC7141534(Au-PeEL)EBL7141534(OCoLC)1354208094(ODN)ODN0010072963(oapen)doab94992(EXLCZ)99571000000009499620221116d2023 u| 0engurnn#008mamaatxtrdacontentcrdamediacrrdacarrierQuantitative Models in Life Science Business From Value Creation to Business Processes /edited by Jung Kyu Canci, Philipp Mekler, Gang Mu1st ed. 2023.2022Cham :Springer International Publishing :Imprint: Springer,2023.1 online resource (IX, 127 p. 25 illus., 13 illus. in color.)SpringerBriefs in Economics,2191-55123-031-11813-8 Part I. Value Creation and Managing Intellectual Property in the Life Science Industry -- Chapter 1. Value Creation, Valuation and Business Models in the Pharmaceutical Sector -- Chapter 2. Alternative Licensing Strategies: A Piecewise Deterministic Differential Game -- Chapter 3. Partnership Models for R&D in the Pharmaceutical Industry -- Part II. Modelling Specific Business Processes in the Life Science Industry -- Chapter 4. Pharma Tender Processes: Modelling Auction Outcomes -- Chapter 5. Multi-Echelon Inventory Optimization Using Deep Reinforcement Learning -- Part III. Specialized Quantitative Tools in the Life Science Industry -- Chapter 6. Stochastic Differential Equations in Healthcare -- Chapter 7. Point Processes with Mixed Doubly Stochastic Poisson and Self-Exciting Flavors: An Excursion Into DALY Computations.This open access book explores the field of life science business from a multidisciplinary perspective. Applying statistical, mathematical, game-theoretic, and data science tools to pharmaceutical and biotechnology business endeavors, the book describes value creation, value maintenance, and value realization in the life sciences as a sequence of processes using the quantitative language of applied mathematics. Written by experts from a variety of fields, the contributions illustrate the shift from a deterministic to a stochastic view of the processes involved, offering a new perspective on life sciences economics. The book covers topics such as valuing and managing intellectual property in life science, licensing in the pharmaceutical business, outsourcing pharmaceutical R&D, and stochastic modelling of a pharmaceutical supply chain. The book will appeal to scholars of economics and the life sciences, as well as to professionals in chemical and pharmaceutical industries. .SpringerBriefs in Economics,2191-5512Medical economicsPharmaceutical chemistryTechnological innovationsMedicineResearchBiologyResearchBiotechnologyEconometricsHealth EconomicsPharmaceuticsEconomics of InnovationBiomedical ResearchBiotechnologyQuantitative EconomicsMedical economics.Pharmaceutical chemistry.Technological innovations.MedicineResearch.BiologyResearch.Biotechnology.Econometrics.Health Economics.Pharmaceutics.Economics of Innovation.Biomedical Research.Biotechnology.Quantitative Economics.338.4761BUS000000BUS069000BUS069030MED000000MED072000SCI010000bisacshCanci Jung Kyuedt429628Canci Jung Kyuedthttp://id.loc.gov/vocabulary/relators/edtMekler Philippedthttp://id.loc.gov/vocabulary/relators/edtMu Gangedthttp://id.loc.gov/vocabulary/relators/edtMiAaPQMiAaPQMiAaPQBOOK9910631082503321Quantitative Models in Life Science Business3034615UNINA